# Guangdong Bawei Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/guangdong-bawei-biotechnology-co

- Industry: Consumer Products
- Headquarters: China
- Total disclosed funding: $16M
- Latest round: Series B (Jan 5, 2022)
- Investors on record: 2

## About

Founded in 2006 and based in China, Guangdong Bawei Biotechnology Co., Ltd. operates as a cosmetics processing company. Bawei serves nearly 2,000 cosmetic brand customers. In January 2022, Guangdong Bayway Biotechnology Co., Ltd. raised CNY 100 million in Series B funding from Baiyun Fund and Jinding Capital.

The company provides integrating professional planning, research and development, and production of cosmetics products in the market.

The enterprise plans to use the January 2022 funding to invest in digital intelligence factory renovation to expand production capacity and improve the utilization rate and strengthen the company's technical barriers to competition in the application of raw materials and formula research and development.

## Funding rounds

- Series B, Jan 5, 2022, $16M — Jinding Capital, Baiyun Fund

## Investors

- Jinding Capital (https://capitalatlas.ai/funds/jinding-capital) — Series B
- Baiyun Fund (https://capitalatlas.ai/funds/baiyun-fund) — Series B